Published in Am J Pathol on October 01, 1984
High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis. Ann Rheum Dis (2002) 1.67
Nutrition and autoimmunity: a review. Clin Exp Immunol (1986) 1.09
Calories versus protein in onset of renal disease in NZB x NZW mice. Proc Natl Acad Sci U S A (1986) 0.93
Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51
Enzymatic determination of total serum cholesterol. Clin Chem (1974) 20.65
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99
Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies. Immunochemistry (1969) 11.46
Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem (1973) 8.51
Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem (1983) 7.70
Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science (1982) 3.59
Regulation of the immune response by prostaglandins. J Clin Immunol (1983) 3.12
Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45
Single nutrients and immunity. Am J Clin Nutr (1982) 1.88
Lipoproteins and atherosclerosis. A look back and a look ahead. Arteriosclerosis (1983) 1.45
Dietary restrictions early and late: effects on the nephropathy of the NZB X NZW mouse. Lab Invest (1978) 1.45
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41
Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome. Am J Pathol (1979) 1.39
Influence of controlled dietary restriction on immunologic function and aging. Fed Proc (1979) 1.39
Influence of protein restriction on immune functions in NZB mice. J Immunol (1976) 1.36
Dietary influence on breeding behavior, hemolytic anemia, and longevity in NZB mice. Proc Soc Exp Biol Med (1972) 1.22
Dietary influence on antinuclear antibodies and cell-mediated immunity in NZB mice. Int Arch Allergy Appl Immunol (1973) 1.19
Reduction of circulating immune complexes by calorie restriction in (NZB x NZW) F1 mice. Clin Immunol Immunopathol (1980) 1.14
Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum. Clin Exp Immunol (1980) 1.12
Nutritional deficiency, immunologic function, and disease. Am J Pathol (1976) 1.11
Modulating effects of canine high density lipoproteins on cholesteryl ester synthesis induced by beta-very low density lipoproteins in macrophages. Possible in vitro correlates with atherosclerosis. Arteriosclerosis (1982) 1.08
Autoimmune diseases: immunopathology and etiopathogenesis. Am J Pathol (1982) 1.07
Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice. Proc Natl Acad Sci U S A (1982) 1.07
Influence of dietary restriction and aging on natural killer cell activity in mice. J Immunol (1983) 1.05
Influence of dietary fat concentration and saturation on immune ontogeny in mice. J Nutr (1980) 0.95
Influence of diet on vascular lesions in autoimmune-prone B/W mice. Proc Natl Acad Sci U S A (1983) 0.91
Albumin determination by a modified bromcresol green method. Clin Chem (1977) 0.87
Antigen-induced in vitro inhibition of immune responsiveness. Cell Immunol (1981) 0.87
Influence of diet and feed restriction on kidney function of aging male rats. J Gerontol (1976) 0.87
Effects of essential fatty acid deficiency, and various levels of dietary polyunsaturated fatty acids, on humoral immunity in mice. J Nutr (1979) 0.86
The effect of quality and quantity of dietary fat on the immune system. J Nutr (1983) 0.85
Correlations between membrane viscosity, serum cholesterol, lymphocyte activation and aging in man. Mech Ageing Dev (1980) 0.83
Reduction of casein-induced hypercholesterolaemia and atherosclerosis in rabbits and rats by dietary glycine, arginine and alanine. Atherosclerosis (1982) 0.82
Enriched lipid diet accelerates lupus nephritis in NZB x W mice. Synergistic action of immune complexes and lipid in glomerular injury. Am J Pathol (1983) 0.82
Genetic susceptibility and resistance to diet-induced atherosclerosis and hyperlipoproteinemia. Arteriosclerosis (1982) 0.81
Effects of dietary fatty acids on delayed-type hypersensitivity in mice. J Nutr (1981) 0.81
Membrane receptors for very low density lipoprotein (VLDL) inhibitor of lymphocyte proliferation. Blood (1981) 0.80
Influence of weaning-initiated dietary restriction on responses to T cell mitogens and on splenic T cell levels in a long-lived F1-hybrid mouse strain. Exp Gerontol (1982) 0.79
Sperm-related antigens, antibodies, and circulating immune complexes in sera of recently vasectomized men. J Clin Invest (1982) 0.79
Food preference and length of life. Science (1975) 0.78
The effect of semipurified diets containing different proportions of either casein or soybean protein on the concentration of cholesterol in whole serum, serum lipoproteins and liver in male and female rats. Atherosclerosis (1982) 0.78
Viscosity of lymphocyte plasma membrane in aging mice and its possible relation to serum cholesterol. Mech Ageing Dev (1979) 0.78
Life-long dietary protein restriction and immune function: responses to mitogens and sheep erythrocytes in BALB/c mice. Am J Clin Nutr (1980) 0.77
Dietary behavior and longevity. Nutr Rev (1977) 0.77
Secretion of cholesterol, triglyceride and apolipoprotein A-I by isolated perfused liver from rats fed soybean protein and casein or their amino acid mixtures. J Nutr (1982) 0.76
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest (1967) 9.01
Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (1976) 5.50
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med (1976) 4.63
Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet (1968) 4.41
Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38
The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07
Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97
The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res (2000) 3.83
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med (1968) 3.54
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg (1995) 3.24
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation (1987) 3.16
Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12
Distribution of brain metastases. Arch Neurol (1988) 3.11
Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med (1977) 3.06
Clinical classification of cardiac deaths. Circulation (1982) 2.93
Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89
Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst (1995) 2.70
Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells. J Exp Med (1977) 2.66
Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol (1967) 2.64
The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53
C2 deficiency. Development of lupus erythematosus. J Clin Invest (1973) 2.52
A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females. Lancet (1967) 2.47
Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res (1994) 2.46
Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45
An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. Proc Natl Acad Sci U S A (1992) 2.43
Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41
The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38
Effects of protein insufficiency on immune responsiveness. Am J Clin Nutr (1974) 2.37
Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes. J Exp Med (1969) 2.36
Chemical suppression of adaptive immunity. Adv Immunol (1967) 2.35
Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A (1981) 2.33
NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol (1993) 2.32
Impaired lymphocyte function in aged humans. J Clin Invest (1974) 2.32
Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer (1971) 2.31
Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med (1968) 2.31
Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol (1996) 2.30
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med (1993) 2.22
Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med (1976) 2.18
Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16
Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients. J Clin Invest (1976) 2.15
Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology (1990) 2.13
Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med (1968) 2.11
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol (1969) 2.06
Kaposi's sarcoma: a review and recent developments. CA Cancer J Clin (1981) 2.05
Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest (1981) 2.04
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A (1999) 2.04
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci U S A (1985) 2.04
Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03
Phytohaemagglutinin unresponsiveness of lymphocytes from babies with congenital rubella. Nature (1967) 1.99
Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage. J Exp Med (1972) 1.99
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97
The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96
Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med (1980) 1.94
The memorial symptom assessment scale short form (MSAS-SF). Cancer (2000) 1.94
Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94
Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94
Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92
Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation. J Exp Med (1977) 1.91
Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87
The measurement of symptoms in children with cancer. J Pain Symptom Manage (2000) 1.85
Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol (1997) 1.84
Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
A proposed classification of primary immunologic deficiencies. Am J Med (1968) 1.83
Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med (1968) 1.82
New goals for education in geriatric medicine. Ann Intern Med (1983) 1.80
Pneumocystis carinii infection. Medicine (Baltimore) (1973) 1.79
Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol (1994) 1.79
Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate. J Allergy Clin Immunol (1998) 1.77
Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol (1977) 1.76
Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76
Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75
Absence of enhancing antibody in cell mediated immunity to tumour heterografts in protein deficient rats. Nature (1971) 1.74
N.B.T. test stimulated. Lancet (1970) 1.73
B and T lymphocytes in primary immunodeficiency disease in man. J Clin Invest (1973) 1.72
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sci U S A (1976) 1.71
Biosynthesis and secretion of immunoglobulins by peripheral-blood lymphocytes in severe hypogammaglobulinaemia. Lancet (1972) 1.71
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (1981) 1.70
Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med (1966) 1.69
Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69
Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging, and involution of immunologic capacity. Lab Invest (1970) 1.69
The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest (1979) 1.67